Tenderwize
Wróć do wyszukiwania

Framework Agreement for Supply of Adalimumab and Golimumab

Consorci de Salut i d'Atenció Social de Catalunya·No consta, Spain·Expired · Jul 09, 2026·Open·Supplies·Framework
Zarejestruj się, aby zapisaćOpen documents
Structured notice only
Oryginalny tytuł ogłoszenia

Spain – Various medicinal products – ACUERDO MARCO DEL SUMINISTRO DE LOS MEDICAMENTOS ADALIMUMAB Y GOLIMUMAB

30/100

Ocena szansy

Needs reviewMedium complexity
SuppliesFrameworkExpired
Skąd ta ocena?

Szansa

30 / 100

Złożoność

40 / 100

Czynniki ryzyka

No estimated value is provided; the true contract value is unknown, which may affect bid/no-bid decisions and resource...

Award criteria and selection criteria are not specified, making it impossible to assess the likelihood of winning or pr...

Głęboka analiza portfolio

Głęboka analiza dopasowania firmy

Wykorzystuje:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Przegląd

Moderate opportunity

Kluczowe fakty

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration 1 YEAR
  • Supply of various medicinal products specifically Adalimumab and Golimumab.
  • Framework agreement for multiple contracts with healthcare providers in Catalonia.
Pokaż pełne podsumowanie

This tender is a framework agreement for the supply of medicinal products Adalimumab and Golimumab, managed by Consorci de Salut i d'Atenció Social de Catalunya for the Catalonia region (Spain). The procedure is open with electronic submission required. The notice lacks estimated value, award criteria, and selection criteria, increasing uncertainty. The deadline for submission is 2026-07-09T13:00:00 (local time). One lot covers all supplies. The framework agreement duration is stated as 1 year, but the XML notice suggests a possible 48-month duration, creating inconsistency.

Ryzyka

No estimated value is provided; the true contract value is unknown, which may affect bid/no-bid decisions and resource...

Award criteria and selection criteria are not specified, making it impossible to assess the likelihood of winning or pr...

Analiza może być niepełna

Przeanalizowano tylko część dokumentacji. Pozostałe dokumenty mogą zawierać dodatkowe wymagania, certyfikaty lub dokumenty do złożenia.

Kluczowe wymagania

Technical

  • Tenders must be in Catalan (and possibly Spanish based on XML).

Administrative

  • Electronic submission is mandatory.
  • Tenders must be submitted via the provided URL.

Wymagania mogą być niepełne.

Kryteria udzielenia

Lot 1

Award criteria not specified in the structured data or notice.

Zamawiający

Lokalizacja

No consta, ESP

Identyfikator

8885209

Działalność

Health

Części (1)

LOT-0000

Framework Agreement for Supply of Adalimumab and Golimumab

Single lot covering the supply of various medicinal products, specifically Adalimumab and Golimumab. The framework agreement is for supplies, and the scope is the provision of these medicines to healthcare entities in Catalonia.

SuppliesFrameworkEU fundedElectronic submission

Lokalizacja

Spain

Czas trwania

1 YEAR

Kategoria

Medicinal products

Kryteria udzielenia

Award criteria not specified in the structured data or notice.

Termin

Expired Jul 09, 2026

Szczegóły zamówienia

Data publikacji
02 Jun 2026
Języki
Spanish, Cat

Metadane referencyjne

Podstawa prawna
32014L0024

Identyfikatory referencyjne

ID przetargu
379033-2026

Dokumenty (1)

Dokument zamówienia 1

Podobne przetargi

Poland – Various medicinal products – Dostawa produktów leczniczych, nr PN-127/26/TM

Sep 7

Belgium – Various medicinal products – Leveren van paracetamol oplossing voor intraveneus gebruik voor de ziekenhuisapotheek

Aug 27

Belgium – Anaesthetics – LEVEREN VAN ROCURONIUM 50 MG/ 5 ML VOOR INTRAVENEUS GEBRUIK

Aug 25

France – Various medicinal products – FOURNITURE DE MEDICAMENTS RADIOPHARMACEUTIQUES (TEP et SCINTI) ______________________________________________________________________

Sep 10

Belgium – Medicinal products for the respiratory system – LEVEREN VAN PIRFENIDONE 267 mg en 801 mg (filmomhulde) tabletten

Sep 14

Norway – Medical equipments, pharmaceuticals and personal care products – 2801c Medicines infusion injection

Sep 17